IL123220A0 - Ibogamine congeners - Google Patents
Ibogamine congenersInfo
- Publication number
- IL123220A0 IL123220A0 IL12322096A IL12322096A IL123220A0 IL 123220 A0 IL123220 A0 IL 123220A0 IL 12322096 A IL12322096 A IL 12322096A IL 12322096 A IL12322096 A IL 12322096A IL 123220 A0 IL123220 A0 IL 123220A0
- Authority
- IL
- Israel
- Prior art keywords
- substituted alkyl
- unsubstituted
- group
- alkyl
- nhr8
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Glass Compositions (AREA)
- Executing Machine-Instructions (AREA)
- Oscillators With Electromechanical Resonators (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US204895P | 1995-08-08 | 1995-08-08 | |
PCT/US1996/012627 WO1997005869A1 (en) | 1995-08-08 | 1996-08-02 | Ibogamine congeners |
Publications (1)
Publication Number | Publication Date |
---|---|
IL123220A0 true IL123220A0 (en) | 1998-09-24 |
Family
ID=21699020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12322096A IL123220A0 (en) | 1995-08-08 | 1996-08-02 | Ibogamine congeners |
Country Status (6)
Country | Link |
---|---|
US (1) | US6211360B1 (xx) |
EP (1) | EP0859610B1 (xx) |
AT (1) | ATE315389T1 (xx) |
DE (1) | DE69635737D1 (xx) |
IL (1) | IL123220A0 (xx) |
WO (1) | WO1997005869A1 (xx) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780871B2 (en) | 2001-01-29 | 2004-08-24 | Albany Medical College | Methods and compositions for treating addiction disorders |
BR0106261A (pt) * | 2001-12-26 | 2003-09-02 | Fundacao Oswaldo Cruz | Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids |
US20030199496A1 (en) * | 2002-04-22 | 2003-10-23 | Simon David Lew | Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use |
US20050251442A1 (en) * | 2004-05-07 | 2005-11-10 | Joseph Ficalora | Consumer incentive system and business method |
AU2009209276B2 (en) * | 2008-01-28 | 2014-06-05 | Albany Medical College | Use of ibogamine congeners for treating obesity |
US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
US8362007B1 (en) | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
US8741891B1 (en) | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
US9358237B2 (en) | 2010-07-23 | 2016-06-07 | Demerx, Inc. | Noribogaine compositions |
EP2481740B1 (en) * | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
US8742096B2 (en) * | 2011-03-28 | 2014-06-03 | Demerx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
WO2013085922A1 (en) | 2011-12-09 | 2013-06-13 | Demerx, Inc. | Phosphate esters of noribogaine |
WO2013085849A2 (en) * | 2011-12-09 | 2013-06-13 | Demerx, Inc. | Sulfate esters of noribogaine |
US20130178618A1 (en) | 2012-01-10 | 2013-07-11 | William Allen Boulanger | Novel pharmaceutical intermediates and methods for preparing the same |
US8877921B2 (en) | 2012-01-25 | 2014-11-04 | Demerx, Inc. | Synthetic voacangine |
US9150584B2 (en) | 2012-01-25 | 2015-10-06 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
CA2908240A1 (en) * | 2012-03-27 | 2013-10-03 | Albany Medical College | Blocking of cue-induced drug reinstatement |
US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
JP2016508979A (ja) * | 2012-12-20 | 2016-03-24 | デメレックス, インコーポレイテッド | 置換ノルイボガイン |
US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
AU2014208382A1 (en) | 2013-01-24 | 2015-07-23 | Tylerton International Holdings Inc. | Body structure imaging |
US20150366523A1 (en) | 2013-01-24 | 2015-12-24 | Shlomo Ben-Haim | Neuronal imaging and treatment |
WO2015033319A2 (en) | 2013-09-08 | 2015-03-12 | Shlomo Ben-Haim | Apparatus and methods for diagnosis and treatment of patterns of nervous system activity affecting disease |
WO2015104672A2 (en) | 2014-01-10 | 2015-07-16 | Tylerton International Holdings Inc. | Detection of scar and fibrous cardiac zones |
WO2015195673A2 (en) | 2014-06-18 | 2015-12-23 | Demerx, Inc. | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them |
CN105491951B (zh) | 2014-07-30 | 2020-11-20 | 纳维斯国际有限公司 | 配准核医学数据 |
WO2021178691A1 (en) * | 2020-03-05 | 2021-09-10 | The Trustees Of Columbia University In The City Of New York | Ibogaine analogs as therapeutics for neurological and psychiatric disorders |
US11680066B2 (en) * | 2020-05-18 | 2023-06-20 | Jeffrey Alan McKinney | Ibogaine-related compounds and corresponding methods |
US12116372B1 (en) | 2023-12-14 | 2024-10-15 | William Allen Boulanger | Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH434281A (de) * | 1964-03-04 | 1967-04-30 | Geigy Ag J R | Verfahren zur Herstellung von polycyclischen Indolderivaten |
US3681362A (en) * | 1968-06-29 | 1972-08-01 | Shionogi & Co | Process for the preparation of isoquinuclidine alkaloids |
GB1445287A (en) * | 1973-10-24 | 1976-08-11 | Omnium Chimique Sa | Derivatives of iboga type alkaloids |
FR2296418B1 (xx) * | 1974-12-30 | 1978-07-21 | Anvar | |
US4499096A (en) * | 1983-11-18 | 1985-02-12 | Lotsof Howard S | Rapid method for interrupting the narcotic addiction syndrome |
US4587243A (en) * | 1985-07-15 | 1986-05-06 | Lotsof Howard S | Rapid method for interrupting the cocaine and amphetamine abuse syndrome |
JPH0341081A (ja) * | 1989-07-10 | 1991-02-21 | Mitsui Petrochem Ind Ltd | 二量体アルカロイド類の製造方法 |
US5152994A (en) | 1990-05-31 | 1992-10-06 | Lotsof Howard S | Rapid method for interrupting or attenuating poly-drug dependency syndromes |
JPH0559053A (ja) * | 1991-02-28 | 1993-03-09 | Mikio Yamazaki | インドールアルカロイド化合物 |
-
1996
- 1996-08-02 WO PCT/US1996/012627 patent/WO1997005869A1/en active IP Right Grant
- 1996-08-02 IL IL12322096A patent/IL123220A0/xx unknown
- 1996-08-02 AT AT96928041T patent/ATE315389T1/de not_active IP Right Cessation
- 1996-08-02 DE DE69635737T patent/DE69635737D1/de not_active Expired - Lifetime
- 1996-08-02 EP EP96928041A patent/EP0859610B1/en not_active Expired - Lifetime
- 1996-08-02 US US09/011,809 patent/US6211360B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0859610A1 (en) | 1998-08-26 |
WO1997005869A1 (en) | 1997-02-20 |
ATE315389T1 (de) | 2006-02-15 |
EP0859610B1 (en) | 2006-01-11 |
EP0859610A4 (en) | 2002-05-15 |
US6211360B1 (en) | 2001-04-03 |
DE69635737D1 (de) | 2006-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL123220A0 (en) | Ibogamine congeners | |
IL115903A0 (en) | Use of dioxomorpholines for combating endoparasites new dioxomorpholines and processes for their preparation | |
HUP0102471A2 (hu) | 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények | |
TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
FI953838A (fi) | Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa | |
MX9203018A (es) | Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados. | |
IL114794A0 (en) | Peptidic compounds analogous to distramycin process for their preparation and their use | |
BG104996A (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
DE69809754D1 (en) | Substituierte 6-phenylphenanthridine | |
ATE209186T1 (de) | Überbrückte azabicyclische derivate als substanz p antagonisten | |
ATE219765T1 (de) | Indolderivate als cgmp-pde inhibitoren | |
ZA955223B (en) | Substituted azaindolylidene compounds and process for their preparation | |
YU27697A (sh) | Sulfonamidi i njihiova upotreba | |
FI970147A (fi) | Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina | |
DK0561941T3 (da) | N-Substituerede lactamer anvendelige som cholecystokinin-antagonister | |
EP0938317A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION | |
EP1140900A4 (en) | PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS | |
TW342385B (en) | Bicyclic benzazepin, the process for their preparation and the pharmaceutical composition containing them | |
AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
ES8608503A1 (es) | Procedimiento para la fabricacion de nuevos derivados de la cumarina | |
IS4367A (is) | CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín | |
PL328266A1 (en) | Therapeutic compounds | |
IL104657A0 (en) | Benzazepine derivatives,their preparation and pharmaceutical compositions containing them | |
GB9308431D0 (en) | Chemical compounds | |
ES2103832T3 (es) | Derivados de 2-fenil y 2-tienil-(2)-piperidina que tienen propiedades neuroprotectoras. |